0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Animal Vaccine Adjuvant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-10Q14587
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Animal Vaccine Adjuvant Market Research Report 2023
BUY CHAPTERS

Animal Vaccine Adjuvant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-10Q14587
Report
November 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Animal Vaccine Adjuvant - Market Size

The global market for Animal Vaccine Adjuvant was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 496.5 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030

Animal Vaccine Adjuvant - Market

Animal Vaccine Adjuvant - Market

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Globally, dog and cat ownership is gaining popularity, especially after the pandemic. Such an increase in the rate of pet ownership across the world is expected to boost the market's growth. The increasing animal health expenditure by owners to ensure better diagnosis and treatment and increasing pet ownership are expected to positively impact the veterinary vaccine adjuvants market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Animal Vaccine Adjuvant, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Animal Vaccine Adjuvant by region & country, by Type, and by Application.
The Animal Vaccine Adjuvant market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Vaccine Adjuvant.
Market Segmentation

Scope of Animal Vaccine Adjuvant - Market Report

Report Metric Details
Report Name Animal Vaccine Adjuvant - Market
Forecasted market size in 2030 US$ 496.5 million
CAGR 6.0%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Croda, SEPPIC, SDA BIO, SPI Pharma, MVP Laboratories, Zhuoyue, Zhiju Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Animal Vaccine Adjuvant manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Animal Vaccine Adjuvant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Animal Vaccine Adjuvant in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Animal Vaccine Adjuvant - Market size in 2030?

Ans: The Animal Vaccine Adjuvant - Market size in 2030 will be US$ 496.5 million.

Who are the main players in the Animal Vaccine Adjuvant - Market report?

Ans: The main players in the Animal Vaccine Adjuvant - Market are Croda, SEPPIC, SDA BIO, SPI Pharma, MVP Laboratories, Zhuoyue, Zhiju Bio

What are the Application segmentation covered in the Animal Vaccine Adjuvant - Market report?

Ans: The Applications covered in the Animal Vaccine Adjuvant - Market report are Livestock Vaccines, Companion Animals Vaccines

What are the Type segmentation covered in the Animal Vaccine Adjuvant - Market report?

Ans: The Types covered in the Animal Vaccine Adjuvant - Market report are Oral, Subcutaneous, Intramuscular, Others

Recommended Reports

Animal Vaccine Markets

Vaccine Adjuvant Reports

Companion & Pet Vaccines

1 Market Overview
1.1 Animal Vaccine Adjuvant Product Introduction
1.2 Global Animal Vaccine Adjuvant Market Size Forecast
1.3 Animal Vaccine Adjuvant Market Trends & Drivers
1.3.1 Animal Vaccine Adjuvant Industry Trends
1.3.2 Animal Vaccine Adjuvant Market Drivers & Opportunity
1.3.3 Animal Vaccine Adjuvant Market Challenges
1.3.4 Animal Vaccine Adjuvant Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal Vaccine Adjuvant Players Revenue Ranking (2023)
2.2 Global Animal Vaccine Adjuvant Revenue by Company (2019-2024)
2.3 Key Companies Animal Vaccine Adjuvant Manufacturing Base Distribution and Headquarters
2.4 Key Companies Animal Vaccine Adjuvant Product Offered
2.5 Key Companies Time to Begin Mass Production of Animal Vaccine Adjuvant
2.6 Animal Vaccine Adjuvant Market Competitive Analysis
2.6.1 Animal Vaccine Adjuvant Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Animal Vaccine Adjuvant Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Vaccine Adjuvant as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Subcutaneous
3.1.3 Intramuscular
3.1.4 Others
3.2 Global Animal Vaccine Adjuvant Sales Value by Type
3.2.1 Global Animal Vaccine Adjuvant Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Animal Vaccine Adjuvant Sales Value, by Type (2019-2030)
3.2.3 Global Animal Vaccine Adjuvant Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Livestock Vaccines
4.1.2 Companion Animals Vaccines
4.2 Global Animal Vaccine Adjuvant Sales Value by Application
4.2.1 Global Animal Vaccine Adjuvant Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Animal Vaccine Adjuvant Sales Value, by Application (2019-2030)
4.2.3 Global Animal Vaccine Adjuvant Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Animal Vaccine Adjuvant Sales Value by Region
5.1.1 Global Animal Vaccine Adjuvant Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Animal Vaccine Adjuvant Sales Value by Region (2019-2024)
5.1.3 Global Animal Vaccine Adjuvant Sales Value by Region (2025-2030)
5.1.4 Global Animal Vaccine Adjuvant Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Animal Vaccine Adjuvant Sales Value, 2019-2030
5.2.2 North America Animal Vaccine Adjuvant Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Animal Vaccine Adjuvant Sales Value, 2019-2030
5.3.2 Europe Animal Vaccine Adjuvant Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Animal Vaccine Adjuvant Sales Value, 2019-2030
5.4.2 Asia Pacific Animal Vaccine Adjuvant Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Animal Vaccine Adjuvant Sales Value, 2019-2030
5.5.2 South America Animal Vaccine Adjuvant Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Animal Vaccine Adjuvant Sales Value, 2019-2030
5.6.2 Middle East & Africa Animal Vaccine Adjuvant Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal Vaccine Adjuvant Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Animal Vaccine Adjuvant Sales Value
6.3 United States
6.3.1 United States Animal Vaccine Adjuvant Sales Value, 2019-2030
6.3.2 United States Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Animal Vaccine Adjuvant Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Animal Vaccine Adjuvant Sales Value, 2019-2030
6.4.2 Europe Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Animal Vaccine Adjuvant Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Animal Vaccine Adjuvant Sales Value, 2019-2030
6.5.2 China Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
6.5.3 China Animal Vaccine Adjuvant Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Animal Vaccine Adjuvant Sales Value, 2019-2030
6.6.2 Japan Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Animal Vaccine Adjuvant Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Animal Vaccine Adjuvant Sales Value, 2019-2030
6.7.2 South Korea Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Animal Vaccine Adjuvant Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Animal Vaccine Adjuvant Sales Value, 2019-2030
6.8.2 Southeast Asia Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Animal Vaccine Adjuvant Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Animal Vaccine Adjuvant Sales Value, 2019-2030
6.9.2 India Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
6.9.3 India Animal Vaccine Adjuvant Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Croda
7.1.1 Croda Profile
7.1.2 Croda Main Business
7.1.3 Croda Animal Vaccine Adjuvant Products, Services and Solutions
7.1.4 Croda Animal Vaccine Adjuvant Revenue (US$ Million) & (2019-2024)
7.1.5 Croda Recent Developments
7.2 SEPPIC
7.2.1 SEPPIC Profile
7.2.2 SEPPIC Main Business
7.2.3 SEPPIC Animal Vaccine Adjuvant Products, Services and Solutions
7.2.4 SEPPIC Animal Vaccine Adjuvant Revenue (US$ Million) & (2019-2024)
7.2.5 SEPPIC Recent Developments
7.3 SDA BIO
7.3.1 SDA BIO Profile
7.3.2 SDA BIO Main Business
7.3.3 SDA BIO Animal Vaccine Adjuvant Products, Services and Solutions
7.3.4 SDA BIO Animal Vaccine Adjuvant Revenue (US$ Million) & (2019-2024)
7.3.5 SPI Pharma Recent Developments
7.4 SPI Pharma
7.4.1 SPI Pharma Profile
7.4.2 SPI Pharma Main Business
7.4.3 SPI Pharma Animal Vaccine Adjuvant Products, Services and Solutions
7.4.4 SPI Pharma Animal Vaccine Adjuvant Revenue (US$ Million) & (2019-2024)
7.4.5 SPI Pharma Recent Developments
7.5 MVP Laboratories
7.5.1 MVP Laboratories Profile
7.5.2 MVP Laboratories Main Business
7.5.3 MVP Laboratories Animal Vaccine Adjuvant Products, Services and Solutions
7.5.4 MVP Laboratories Animal Vaccine Adjuvant Revenue (US$ Million) & (2019-2024)
7.5.5 MVP Laboratories Recent Developments
7.6 Zhuoyue
7.6.1 Zhuoyue Profile
7.6.2 Zhuoyue Main Business
7.6.3 Zhuoyue Animal Vaccine Adjuvant Products, Services and Solutions
7.6.4 Zhuoyue Animal Vaccine Adjuvant Revenue (US$ Million) & (2019-2024)
7.6.5 Zhuoyue Recent Developments
7.7 Zhiju Bio
7.7.1 Zhiju Bio Profile
7.7.2 Zhiju Bio Main Business
7.7.3 Zhiju Bio Animal Vaccine Adjuvant Products, Services and Solutions
7.7.4 Zhiju Bio Animal Vaccine Adjuvant Revenue (US$ Million) & (2019-2024)
7.7.5 Zhiju Bio Recent Developments
8 Industry Chain Analysis
8.1 Animal Vaccine Adjuvant Industrial Chain
8.2 Animal Vaccine Adjuvant Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal Vaccine Adjuvant Sales Model
8.5.2 Sales Channel
8.5.3 Animal Vaccine Adjuvant Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Animal Vaccine Adjuvant Market Trends
    Table 2. Animal Vaccine Adjuvant Market Drivers & Opportunity
    Table 3. Animal Vaccine Adjuvant Market Challenges
    Table 4. Animal Vaccine Adjuvant Market Restraints
    Table 5. Global Animal Vaccine Adjuvant Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Animal Vaccine Adjuvant Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Animal Vaccine Adjuvant Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Animal Vaccine Adjuvant Product Type
    Table 9. Key Companies Time to Begin Mass Production of Animal Vaccine Adjuvant
    Table 10. Global Animal Vaccine Adjuvant Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Vaccine Adjuvant as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Animal Vaccine Adjuvant Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Animal Vaccine Adjuvant Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Animal Vaccine Adjuvant Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Animal Vaccine Adjuvant Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Animal Vaccine Adjuvant Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Animal Vaccine Adjuvant Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Animal Vaccine Adjuvant Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Animal Vaccine Adjuvant Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Animal Vaccine Adjuvant Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Animal Vaccine Adjuvant Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Animal Vaccine Adjuvant Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Animal Vaccine Adjuvant Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Animal Vaccine Adjuvant Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Animal Vaccine Adjuvant Sales Value by Region (2019-2024) & (%)
    Table 27. Global Animal Vaccine Adjuvant Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Animal Vaccine Adjuvant Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Animal Vaccine Adjuvant Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Animal Vaccine Adjuvant Sales Value, (2025-2030) & (US$ Million)
    Table 31. Croda Basic Information List
    Table 32. Croda Description and Business Overview
    Table 33. Croda Animal Vaccine Adjuvant Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Animal Vaccine Adjuvant Business of Croda (2019-2024)
    Table 35. Croda Recent Developments
    Table 36. SEPPIC Basic Information List
    Table 37. SEPPIC Description and Business Overview
    Table 38. SEPPIC Animal Vaccine Adjuvant Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Animal Vaccine Adjuvant Business of SEPPIC (2019-2024)
    Table 40. SEPPIC Recent Developments
    Table 41. SDA BIO Basic Information List
    Table 42. SDA BIO Description and Business Overview
    Table 43. SDA BIO Animal Vaccine Adjuvant Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Animal Vaccine Adjuvant Business of SDA BIO (2019-2024)
    Table 45. SDA BIO Recent Developments
    Table 46. SPI Pharma Basic Information List
    Table 47. SPI Pharma Description and Business Overview
    Table 48. SPI Pharma Animal Vaccine Adjuvant Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Animal Vaccine Adjuvant Business of SPI Pharma (2019-2024)
    Table 50. SPI Pharma Recent Developments
    Table 51. MVP Laboratories Basic Information List
    Table 52. MVP Laboratories Description and Business Overview
    Table 53. MVP Laboratories Animal Vaccine Adjuvant Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Animal Vaccine Adjuvant Business of MVP Laboratories (2019-2024)
    Table 55. MVP Laboratories Recent Developments
    Table 56. Zhuoyue Basic Information List
    Table 57. Zhuoyue Description and Business Overview
    Table 58. Zhuoyue Animal Vaccine Adjuvant Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Animal Vaccine Adjuvant Business of Zhuoyue (2019-2024)
    Table 60. Zhuoyue Recent Developments
    Table 61. Zhiju Bio Basic Information List
    Table 62. Zhiju Bio Description and Business Overview
    Table 63. Zhiju Bio Animal Vaccine Adjuvant Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Animal Vaccine Adjuvant Business of Zhiju Bio (2019-2024)
    Table 65. Zhiju Bio Recent Developments
    Table 66. Key Raw Materials Lists
    Table 67. Raw Materials Key Suppliers Lists
    Table 68. Animal Vaccine Adjuvant Downstream Customers
    Table 69. Animal Vaccine Adjuvant Distributors List
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
    Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Animal Vaccine Adjuvant Product Picture
    Figure 2. Global Animal Vaccine Adjuvant Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Animal Vaccine Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 4. Animal Vaccine Adjuvant Report Years Considered
    Figure 5. Global Animal Vaccine Adjuvant Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Animal Vaccine Adjuvant Revenue in 2023
    Figure 7. Animal Vaccine Adjuvant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Oral Picture
    Figure 9. Subcutaneous Picture
    Figure 10. Intramuscular Picture
    Figure 11. Others Picture
    Figure 12. Global Animal Vaccine Adjuvant Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Animal Vaccine Adjuvant Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Livestock Vaccines
    Figure 15. Product Picture of Companion Animals Vaccines
    Figure 16. Global Animal Vaccine Adjuvant Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Animal Vaccine Adjuvant Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Animal Vaccine Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Animal Vaccine Adjuvant Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Animal Vaccine Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Animal Vaccine Adjuvant Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Animal Vaccine Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Animal Vaccine Adjuvant Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Animal Vaccine Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Animal Vaccine Adjuvant Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Animal Vaccine Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Animal Vaccine Adjuvant Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Animal Vaccine Adjuvant Sales Value (%), (2019-2030)
    Figure 29. United States Animal Vaccine Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Animal Vaccine Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Animal Vaccine Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Animal Vaccine Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Animal Vaccine Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Animal Vaccine Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Animal Vaccine Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Animal Vaccine Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Animal Vaccine Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Animal Vaccine Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Animal Vaccine Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Animal Vaccine Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Animal Vaccine Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Animal Vaccine Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Animal Vaccine Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 50. Animal Vaccine Adjuvant Industrial Chain
    Figure 51. Animal Vaccine Adjuvant Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String